Immuneering (IMRX) Prepaid Assets (2020 - 2026)
Immuneering (IMRX) posted quarterly Prepaid Assets of $4.7 million for Q1 2026, up 101.48% year-over-year from $2.3 million in Q1 2025, and up 38.1% quarter-over-quarter from $3.4 million in Q4 2025.
Immuneering (IMRX) Prepaid Assets (2020 - 2026) Analysis & Trends
Immuneering's Prepaid Assets history runs 7 years deep, the most recent figure standing at $4.7 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 101.48% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (up 101.48% YoY), while the FY2025 annual figure was $3.4 million, down 0.82% from the prior year.
- Prepaid Assets for Q1 2026 stood at $4.7 million, up from $3.4 million in the prior quarter.
- The five-year high for Prepaid Assets was $4.7 million in Q1 2026, with the low at $890409.0 in Q2 2022.
- The 5-year median for Prepaid Assets is $3.2 million (2024), against an average of $2.9 million.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets surged 183.21% in 2023, then plunged 66.56% in 2025.
- Immuneering's Prepaid Assets stood at $3.2 million in 2022, then climbed by 6.49% to $3.4 million in 2023, then increased by 0.73% to $3.4 million in 2024, then retreated by 0.82% to $3.4 million in 2025, then soared by 38.1% to $4.7 million in 2026.
- Business Quant data shows IMRX's Prepaid Assets at $4.7 million in Q1 2026, $3.4 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immuneering | 327.37 Mn | 327.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.09 Mn |
| Mar 31, 2026 | 4.72 Mn |
| Dec 31, 2025 | 3.41 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Dec 31, 2024 | 3.44 Mn |
| Sep 30, 2024 | 4.60 Mn |
| Jun 30, 2024 | 3.96 Mn |
| Mar 31, 2024 | 3.17 Mn |
| Dec 31, 2023 | 3.42 Mn |
| Sep 30, 2023 | 3.34 Mn |
| Jun 30, 2023 | 2.52 Mn |
| Mar 31, 2023 | 2.70 Mn |
| Dec 31, 2022 | 3.21 Mn |
| Sep 30, 2022 | 2.76 Mn |
| Jun 30, 2022 | 890,409.00 |
| Mar 31, 2022 | 1.48 Mn |
| Dec 31, 2021 | 2.89 Mn |
| Sep 30, 2021 | 3.36 Mn |